Firdapse is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Catalyst Pharmaceuticals, Inc.. The primary component is Amifampridine Phosphate.
| Product ID | 69616-211_0cecc1e6-ebdf-480a-be77-f2ef0fcbc897 |
| NDC | 69616-211 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Firdapse |
| Generic Name | Amifampridine Phosphate |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2019-01-07 |
| Marketing Category | NDA / NDA |
| Application Number | NDA208078 |
| Labeler Name | Catalyst Pharmaceuticals, Inc. |
| Substance Name | AMIFAMPRIDINE PHOSPHATE |
| Active Ingredient Strength | 10 mg/1 |
| Pharm Classes | Potassium Channel Blocker [EPC],Potassium Channel Antagonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 2019-01-07 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA208078 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-01-07 |
| Marketing Category | NDA |
| Application Number | NDA208078 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2019-01-07 |
| Marketing Category | NDA |
| Application Number | NDA208078 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-01-07 |
| Marketing Category | NDA |
| Application Number | NDA208078 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-01-07 |
| Ingredient | Strength |
|---|---|
| AMIFAMPRIDINE PHOSPHATE | 10 mg/1 |
| SPL SET ID: | f015fe60-3128-4a43-8c31-19fc6b5def3f |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() FIRDAPSE 86082826 4700764 Live/Registered |
BioMarin Huxley Ltd. 2013-10-04 |
![]() FIRDAPSE 77904586 not registered Dead/Abandoned |
Huxley Pharmaceuticals, Inc. 2010-01-04 |
![]() FIRDAPSE 77830438 not registered Dead/Abandoned |
Huxley Pharmaceuticals, Inc. 2009-09-19 |